TCRX insider transactions
TScan Therapeutics Inc. (TCRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TCRX
- SEC Form 4 filed by Director Baker Bros. Advisors Lp4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Nicholson Garry A4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Woods Keith4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Gruia Gabriela4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Dorton Katina4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Klencke Barbara4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Amello Jason4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Macbeath Gavin4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Officer Dworak Leiden4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Louis Chrystal4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Officer Zdraveski Zoran4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Large owner Lynx1 Capital Management Lp bought $73,552 worth of shares (81,732 units at $0.90) and bought $71,974 worth of shares (80,069 units at $0.90) (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 3 filed by new insider Dworak Leiden3 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Baker Bros. Advisors Lp4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Klencke Barbara4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Nicholson Garry A4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Woods Keith4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Dorton Katina4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Gruia Gabriela4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Large owner Lynx1 Capital Management Lp bought $1,666,553 worth of shares (1,388,794 units at $1.20) and bought $1,440,000 worth of shares (1,200,000 units at $1.20) (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Vice President, Finance Dworak Leiden4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Officer Zdraveski Zoran4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Macbeath Gavin4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Amello Jason4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Louis Chrystal4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Large owner Lynx1 Capital Management Lp4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Large owner Lynx1 Capital Management Lp bought $95,629 worth of shares (31,800 units at $3.01) and bought $290,140 worth of shares (100,000 units at $2.90) (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Large owner Lynx1 Capital Management Lp bought $4,114 worth of shares (947 units at $4.34) (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Director Klencke Barbara bought $26,450 worth of Voting Common Stock (5,000 units at $5.29), increasing direct ownership by 12% to 45,000 units (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Director Klencke Barbara bought $56,100 worth of Voting Common Stock (10,000 units at $5.61), increasing direct ownership by 33% to 40,000 units (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Officer Zdraveski Zoran exercised 157,186 units of Voting Common Stock at a strike of $3.38 and sold $952,116 worth of Voting Common Stock (164,686 units at $5.78), decreasing direct ownership by 61% to 4,716 units (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Gruia Gabriela4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Woods Keith4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Klencke Barbara4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Dorton Katina4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Nicholson Garry A4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 3 filed by new insider Nicholson Garry A3 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Director Baker Bros. Advisors Lp4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Louis Chrystal4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 3 filed by new insider Louis Chrystal3 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Baker Bros. Advisors Lp4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Lynx1 Capital Management Lp4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Amello Jason4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 3 filed by new insider Amello Jason3 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Barberich Timothy J bought $142,456 worth of Voting Common Stock (29,147 units at $4.89), increasing direct ownership by 77% to 67,027 units (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- Klencke Barbara bought $25,400 worth of Voting Common Stock (5,000 units at $5.08), increasing direct ownership by 20% to 30,000 units (SEC Form 4)4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 3 filed by new insider Woods Keith3 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Woods Keith4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Dworak Leiden4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 3: New insider Dworak Leiden claimed ownership of 5,692 units of Voting Common Stock3 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Barberich Timothy J4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Barton Debora4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Dorton Katina4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Gruia Gabriela4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Klencke Barbara4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Silver Brian M.4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Macbeath Gavin4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Zdraveski Zoran4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Baker Bros. Advisors Lp4 - TScan Therapeutics, Inc. (0001783328) (Issuer)
- SEC Form 4 filed by Barberich Timothy J4 - TScan Therapeutics, Inc. (0001783328) (Issuer)